Tumor Necrosis Factor Antibodies

Santa Cruz Biotechnology delivers a wide array of Tumor Necrosis Factor monoclonal antibodies for research focused on tumor necrosis factor (TNF) in various biological processes. Tumor Necrosis Factor Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Tumor necrosis factor is a key cytokine involved in systemic inflammation and serves as a crucial mediator in the immune response. TNF plays a significant role in the regulation of immune cells, the induction of fever, and the promotion of apoptosis. Research has shown that TNF dysregulation is linked to various diseases, including autoimmune disorders and cancer. Understanding TNF's biological functions and mechanisms is vital for developing new therapeutic approaches. Investigating TNF's role in cellular pathways can reveal important insights into disease progression and potential treatments. Exploring TNF signaling networks helps identify novel therapeutic targets and intervention strategies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of TNF's role in human health and disease.